Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $28,588 | 1,427 | 97.3% |
| Travel and Lodging | $700.96 | 1 | 2.4% |
| Education | $52.00 | 12 | 0.2% |
| Consulting Fee | $26.47 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $3,980 | 264 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $3,525 | 175 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $2,280 | 110 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,959 | 97 | $0 (2024) |
| ZOLL Respicardia, Inc. | $1,619 | 9 | $0 (2024) |
| GENZYME CORPORATION | $1,227 | 46 | $0 (2024) |
| Grifols USA, LLC | $1,199 | 54 | $0 (2024) |
| JAZZ PHARMACEUTICALS INC. | $943.32 | 36 | $0 (2024) |
| United Therapeutics Corporation | $940.64 | 44 | $0 (2024) |
| Electromed, Inc. | $885.21 | 74 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,948 | 185 | AstraZeneca Pharmaceuticals LP ($915.73) |
| 2023 | $5,765 | 214 | ZOLL Respicardia, Inc. ($1,438) |
| 2022 | $4,021 | 192 | GlaxoSmithKline, LLC. ($668.87) |
| 2021 | $3,375 | 195 | GlaxoSmithKline, LLC. ($574.17) |
| 2020 | $2,749 | 148 | GlaxoSmithKline, LLC. ($342.69) |
| 2019 | $3,316 | 189 | GlaxoSmithKline, LLC. ($508.54) |
| 2018 | $2,892 | 181 | GlaxoSmithKline, LLC. ($400.40) |
| 2017 | $2,303 | 137 | Actelion Pharmaceuticals US, Inc. ($316.76) |
All Payment Transactions
1,441 individual payment records from CMS Open Payments — Page 1 of 58
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: Respiratory | ||||||
| 12/19/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: Respiratory | ||||||
| 12/19/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $7.39 | General |
| Category: Cardiology | ||||||
| 12/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ARALAST (Biological) | Food and Beverage | In-kind items and services | $21.46 | General |
| Category: IMMUNOLOGY | ||||||
| 12/13/2024 | ZOLL Respicardia, Inc. | remede System (Device) | Food and Beverage | Cash or cash equivalent | $21.14 | General |
| Category: Respiratory | ||||||
| 12/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $20.39 | General |
| Category: RESPIRATORY | ||||||
| 12/12/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $18.92 | General |
| Category: HFCWO | ||||||
| 12/11/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $24.71 | General |
| Category: Pulmonology | ||||||
| 12/11/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: NEUROLOGY | ||||||
| 12/10/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $18.66 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 12/09/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $29.03 | General |
| Category: RESPIRATORY | ||||||
| 12/05/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $7.26 | General |
| Category: Inflammation | ||||||
| 12/04/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $14.78 | General |
| Category: HFCWO | ||||||
| 12/03/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $38.68 | General |
| Category: Immunology | ||||||
| 11/27/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $1.12 | General |
| Category: HFCWO | ||||||
| 11/21/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $138.98 | General |
| Category: Immunology | ||||||
| 11/21/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.60 | General |
| Category: RESPIRATORY | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $20.10 | General |
| Category: Respiratory | ||||||
| 11/15/2024 | Boston Scientific Corporation | Apollo ESG NXT System (Device) | Food and Beverage | In-kind items and services | $40.80 | General |
| Category: Apollo ESG NXT System_ENDO | ||||||
| 11/14/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $7.46 | General |
| Category: HFCWO | ||||||
| 11/13/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $24.14 | General |
| Category: Respiratory | ||||||
| 11/12/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.97 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/12/2024 | Philips North America LLC | (AK6) Vest Therapy (Device) | Food and Beverage | Cash or cash equivalent | $9.42 | General |
| Category: Medical Device | ||||||
| 11/07/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: Cardiology | ||||||
| 11/06/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $135.00 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,860 | 2,645 | $448,595 | $195,577 |
| 2022 | 16 | 1,567 | 2,423 | $432,790 | $191,903 |
| 2021 | 19 | 1,661 | 2,436 | $439,135 | $203,766 |
| 2020 | 17 | 1,284 | 1,937 | $326,600 | $144,836 |
All Medicare Procedures & Services
80 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 597 | 1,157 | $202,475 | $112,256 | 55.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 168 | 168 | $46,200 | $21,237 | 46.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 51 | 97 | $19,400 | $13,607 | 70.1% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Facility | 2023 | 67 | 74 | $41,810 | $7,189 | 17.2% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2023 | 66 | 66 | $18,150 | $6,223 | 34.3% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 111 | 117 | $8,775 | $5,375 | 61.3% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 204 | 242 | $29,040 | $5,188 | 17.9% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 107 | 113 | $9,605 | $4,982 | 51.9% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 153 | 173 | $16,435 | $4,615 | 28.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 51 | 57 | $7,125 | $3,653 | 51.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 13 | 49 | $6,860 | $3,146 | 45.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 12 | 30 | $5,400 | $2,897 | 53.7% |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | Office | 2023 | 53 | 77 | $19,250 | $2,846 | 14.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 52 | 62 | $2,480 | $699.06 | 28.2% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 45 | 50 | $4,750 | $453.40 | 9.5% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 14 | 14 | $1,680 | $438.20 | 26.1% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 33 | 34 | $2,890 | $325.72 | 11.3% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 33 | 34 | $2,550 | $241.74 | 9.5% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2023 | 30 | 31 | $3,720 | $203.98 | 5.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 573 | 1,152 | $201,600 | $113,916 | 56.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 66 | 121 | $24,275 | $17,434 | 71.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 131 | 131 | $36,025 | $16,601 | 46.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 43 | 130 | $18,200 | $7,429 | 40.8% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Facility | 2022 | 52 | 57 | $32,205 | $5,712 | 17.7% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2022 | 50 | 51 | $20,265 | $5,041 | 24.9% |
About Dr. Minh Tran, M.D
Dr. Minh Tran, M.D is a Internal Medicine healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/22/2005. The National Provider Identifier (NPI) number assigned to this provider is 1457334443.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Minh Tran, M.D has received a total of $29,368 in payments from pharmaceutical and medical device companies, with $4,948 received in 2024. These payments were reported across 1,441 transactions from 60 companies. The most common payment nature is "Food and Beverage" ($28,588).
As a Medicare-enrolled provider, Tran has provided services to 6,372 Medicare beneficiaries, totaling 9,441 services with total Medicare billing of $736,082. Data is available for 4 years (2020–2023), covering 80 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Critical Care Medicine, Pulmonary Disease
- Location Houston, TX
- Active Since 11/22/2005
- Last Updated 04/09/2020
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1457334443
Products in Payments
- NUCALA (Biological) $2,065
- DUPIXENT (Biological) $1,880
- remede System (Device) $1,753
- UPTRAVI (Drug) $1,447
- TRELEGY ELLIPTA (Drug) $1,248
- OFEV (Drug) $1,234
- Prolastin-C Liquid (Biological) $1,120
- ACTHAR (Biological) $987.95
- TEZSPIRE (Biological) $914.72
- SMARTVEST (Device) $885.21
- FASENRA (Biological) $801.60
- Adempas (Drug) $653.95
- GLASSIA (Biological) $647.93
- XYWAV (Drug) $579.38
- BREZTRI (Drug) $552.97
- STIOLTO RESPIMAT (Drug) $529.29
- SYMBICORT (Drug) $503.99
- OPSUMIT MACITENTAN (Drug) $473.39
- Arikayce (Drug) $461.26
- (8874) inCourage (Device) $460.28
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Houston
Stephen Pappas, M.d, M.D
Internal Medicine — Payments: $1.6M
Mohamed Othman, Md, MD
Internal Medicine — Payments: $1.1M
Dr. Aung Naing, Md, MD
Internal Medicine — Payments: $925,146
Miguel Escobar, M.d, M.D
Internal Medicine — Payments: $924,228
Dr. Christie Ballantyne, Md, MD
Internal Medicine — Payments: $815,154
John Heymach, M.d, M.D
Internal Medicine — Payments: $786,947